MoneyWorks4Me

Mercury Laboratories - Quaterly Results

26 Jul 2026 Evaluate
The sales slipped to Rs. 159.63 millions for the June 2026 quarter as against Rs. 181.35 millions during the year-ago period.Profit after Tax for the quarter ended June 2026 saw a decline of -69.18% from Rs. 9.67 millions to Rs. 2.98  millions.A decline of 12.44 millions was observed in the OP in the quarter ended June 2026 from 25.35 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 159.63 181.35 -11.98 159.63 181.35 -11.98 759.37 751.01 1.11
Other Income 0.52 1.81 -71.27 0.52 1.81 -71.27 19.55 10.69 82.88
PBIDT 12.44 25.35 -50.93 12.44 25.35 -50.93 109.96 80.85 36.00
Interest 1.23 1.45 -15.17 1.23 1.45 -15.17 5.45 5.48 -0.55
PBDT 11.21 23.90 -53.10 11.21 23.90 -53.10 100.56 75.37 33.42
Depreciation 7.29 8.43 -13.52 7.29 8.43 -13.52 34.20 28.76 18.92
PBT 3.92 15.47 -74.66 3.92 15.47 -74.66 66.36 46.61 42.37
TAX 0.94 5.80 -83.79 0.94 5.80 -83.79 18.03 15.16 18.93
Deferred Tax -0.36 1.00 -136.00 -0.36 1.00 -136.00 1.42 1.68 -15.48
PAT 2.98 9.67 -69.18 2.98 9.67 -69.18 48.33 31.45 53.67
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 7.79 13.98 -44.25 7.79 13.98 -44.25 14.48 10.77 34.51
Peers
Company Name CMP
Sun Pharma. Inds. 1852.05
Dr. Reddys Labs. 1240.35
Cipla 1388.50
Lupin 2071.85
Zydus Lifesciences 1219.95
View more..